Intrapulmonary arteriovenous shunt in children with chronic liver disease: Clinical features, laboratory data and outcome

Indian Journal of Gastroenterology

Volumn 27, Issue 1, 2008, Pages 16-18

  Mahmoodi, Eftekhar ^b   Kianifar, Hamid Reza ^a   Partovi, Simin ^b   Mafinejad, Shahin ^b   Bozorgnia, Abolghasem ^b  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM CHLORIDE;

ADOLESCENT; ARTERIAL GAS; ARTICLE; BIOCHEMISTRY; CHILD; CHRONIC LIVER DISEASE; CLINICAL FEATURE; CONTRAST ECHOCARDIOGRAPHY; CYANOSIS; DEATH; DYSPNEA; FEMALE; FOLLOW UP; HEPATOPULMONARY SYNDROME; HUMAN; LABORATORY; LIVER FUNCTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PULMONARY SHUNT; SPLEEN;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; FEMALE; HEPATOPULMONARY SYNDROME; HUMANS; INFANT; LIVER DISEASES; MALE;

EID: 45349084370     PISSN: 02548860     EISSN: 02548860     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Rodriguez-Roisin R, Krowka MJ, Herve P, Faloon MB, ERS Task Force Pulmonary Hepatic Vascular Disorders (PHD) Scientific Committee. Pulmonary-hepatic vascular disorders. Eur Respir J 2004;24:861-80.
2. Naeije R. Hepatopulmonary syndrome and portopulmonary hypertension. Swiss Med Wkly 2003,133:163-9.
3. Martínez-Pallí G, Drake BB, García-Pagán JC, Barberà JA, Arguedas MR, Rodriguez-Roisin R, et al. Effect of transjugular intrahepatic portosystemic shunt on pulmonary gas exchange in patients with portal hypertension and hepatopulmonary syndrome. World J Gastroenterol 2005;11:6858-62.
4. Lima BL, Franca AV, Pazin-Filho A, Araujo WM, Martinez JA, Maciel BC, et al. Frequency, clinical characteristics and respiratory parameters of hepatopulmonary syndrome. Mayo Clin Proc 2004;79:42-8.
5. Schenk P, Fuhrmann V, Madl C, Funk G, Lehr S, Kandel O, et al. Hepatopulmonary syndrome: prevalence and predictive value of various cut offs for arterial oxygenation and their clinical consequences. Gut 2002;51:853-9.
6. Hira HS, Kumar J, Tyagi SK, Jain SK. A study of hepatopulmonary syndrome among patients of cirrhosis of liver and portal hypertension. Indian J Chest Dis Allied Sci 2003;45:165-71.
7. Anand AC, Mukherjee D, Rao KS, Seth AK. Hepatopulmonary syndrome: prevalence and clinical profile. Indian J Gastroenterol 2001;20:24-7.
8. Schenk P, Schoniger-Hekele M, Fuhrmann V, Madl C, Silberhumer G, Muller C. Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. Gastroenterology 2003;125:1042-52.
9. Barbe T, Losay J, Grimon G, Devictor D, Sardet A, Gauthier F, et al. Pulmonary arteriovenous shunting in children with liver disease. J Pediatr 1995;126:571-9.
10. Bernard O. Pulmonary arteriovenous shunting and pulmonary artery hypertension in children with liver disease. Pediatr Pulmonol 1999;18(Suppl):88-90.
11. Krowka MJ, Wiseman GA, Burnett OL, Spivey JR, Therneau T, Porayko MK, et al. Hepatopulmonary syndrome: a prospective study of relationships between severity of liver disease, PaO2 response to 100% oxygen, and brain uptake after 99mTc MAA lung scanning. Chest 2000;118:615-24.
12. Abrams GA, Jaffe CC, Hoffer PB, Binder HJ, Fallon MB. Diagnostic utility of contrast echocardiography and lung perfusion scan in patients with hepatopulmonary syndrome. Gastroenterology 1995;109:1283-8.